2024/05/10 19:31:36 | |
---|---|
Price | |
9.095 EUR | |
Difference | 1.00% (0.09) |
ISIN | ES0157097017 |
Symbol | ALM |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,918 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 9.04 EUR |
High | 9.095 EUR |
Low | 9.03 EUR |
Close (prev. day) | 9.005 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | 0 |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/05/10 19:31:36 | |
---|---|
Price | |
9.095 EUR | |
Difference | 1.00% (0.09) |
ISIN | ES0157097017 |
Symbol | ALM |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,918 EUR |
Benchmark | IBEX 35 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 9.04 EUR |
High | 9.095 EUR |
Low | 9.03 EUR |
Close (prev. day) | 9.005 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +8.73% | +2.42% | - |
Perf (abs.) | +0.73 | +0.22 | - |
Beta | 0.49 | 0.43 | 0.49 |
Volatility | 20.16 | 21.69 | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 8.882 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 8.354 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 8.365 EUR (30) |
Ø price 250 days | Ø volume 250 days (pcs.) | 8.530 EUR (12) |
YTD High | date | 9.095 EUR (2024/05/10) |
YTD Low | date | 7.870 EUR (2024/03/19) |
52 Weeks High | date | 9.905 EUR (2023/09/20) |
52 Weeks Low | date | 7.375 EUR (2023/06/27) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/05/10 | 09:05 | 9.115 EUR | 0.00 | 3 |
Tradegate | 2024/05/10 | 22:26 | 9.165 EUR | 0.00 | 1 |
Stuttgart | 2024/05/10 | 13:04 | 8.97 EUR | 0.00 | 4 |
Munich | 2024/05/10 | 08:15 | 8.94 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/05/10 | 17:30 | 9.08 EUR | 0.00 | 2 |
Frankfurt | 2024/05/10 | 08:08 | 8.94 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/01/26 | 17:57 | 9.51 USD | 0.00 | 2 |
Duesseldorf | 2024/05/10 | 19:31 | 9.095 EUR | 0.00 | 5 |
Berlin | 2024/05/10 | 08:15 | 8.935 EUR | 0.00 | 2 |
BME Continuous Market | 2024/05/10 | 17:35 | 9.16 EUR | 2.00 | 639 |
ALMIRALL SA |
- - |
General Mitre 151 08022 Barcelona |
Telefon: +34 93 291 30 87 |
Fax: +34 93 291 36 81 |
E-mail: comercial@almirall.es |
- |
Gianfranco Nazzi | Chairman of Managing Board |
Amita Kent | Member of Executive Committee |
Eloi Crespo Cervera | Member of Executive Committee |
Esteve Conesa Panicot | Member of Executive Committee |
Francesca Domenech Wuttke | Member of Executive Committee |
Joan Figueras Carreras | Member of Executive Committee |
Karl Ziegelbauer | Member of Executive Committee |
Mike McClellan | Member of Executive Committee |
Pablo Álvarez | Member of Executive Committee |
Volker Koscielny | Member of Executive Committee |
Alexandra Kimball | Member of Supervisory Board |
Karin Louise Dorrepaal | Member of Supervisory Board |
Ruud Dobber | Member of Supervisory Board |
Seth Orlow | Member of Supervisory Board |
Thomas McKillop | Member of Supervisory Board |
Antonio Gallardo Torrededía | Member of Supervisory Board |
Enrique de Leyva Pérez | Member of Supervisory Board |
Eva-Lotta Allan | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer